Chen Cui
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Association between annular eccentricity and initial post-deployment paravalvular leak before corrective maneuvers in bicuspid aortic valve patients undergoing self-expanding transcatheter aortic valve replacement: a single-center retrospective study.
Journal: Frontiers in cardiovascular medicine
Published: June 15, 2026
Mesenchymal stromal cells ameliorate mitochondrial dysfunction in α cells and hyperglucagonemia in type 2 diabetes via SIRT1/FoxO3a signaling.
Journal: Stem cells translational medicine
Published: November 21, 2023
Didymin protects pancreatic beta cells by enhancing mitochondrial function in high-fat diet-induced impaired glucose tolerance.
Journal: Diabetology & metabolic syndrome
Published: October 04, 2023
Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis.
Journal: Journal of translational medicine
Published: August 02, 2023
Retraction Note: Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy.
Journal: Stem cell research & therapy
Published: October 21, 2022
Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation.
Journal: Stem cell research & therapy
Published: October 08, 2022
Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK/ULK1-mediated autophagy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 21, 2022
cGAS-STING activation contributes to podocyte injury in diabetic kidney disease.
Journal: iScience
Published: January 25, 2022
Author Correction: REV-ERB in GABAergic neurons controls diurnal hepatic insulin sensitivity.
Journal: Nature
Published: June 16, 2021
Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling.
Journal: Molecular and cellular endocrinology
Published: April 15, 2021
Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells.
Journal: Molecular and cellular endocrinology
Published: April 06, 2021
Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation.
Journal: Stem cell research & therapy
Published: March 17, 2021
Last Updated: 09/26/2026